Results 31 to 40 of about 6,983 (156)

Treatments for Molluscum contagiosum: A systematic review

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Molluscum contagiosum (MC) is a viral skin infection that poses significant physical and psychosocial burdens, particularly in pediatric and immunocompromised populations. Despite the availability of various treatment options, comparative efficacy and safety data remain limited.
Ou Jia (Emilie) Wang   +3 more
wiley   +1 more source

Cidofovir intralesional para el tratamiento de la papilomatosis respiratoria recurrente, revisión sistemática de la literatura

open access: yesRevista de la Facultad de Medicina, 2005
Antecedentes. La papilomatosis respiratoria recurrente es una afección viral rara y su tratamiento controvertido. Objetivo. Establecer la efectividad y seguridad del cidofovir como medicamento coadyuvante en el tratamiento de la papilomatosis ...
Gilberto Eduardo Marrugo Pardo   +1 more
doaj  

Historical Perspectives in the Development of Antiviral Agents Against Poxviruses

open access: yesViruses, 2010
The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the ...
Erik De Clercq
doaj   +1 more source

Pharmacokinetic and Efficacy Study of Acyclovir Against Cyprinid Herpesvirus 3 in Cyprinus carpio

open access: yesFrontiers in Veterinary Science, 2020
Cyprinid Herpesvirus 3 (CyHV-3), more commonly known as Koi Herpesvirus (KHV), is a re-emergent virus causing acute systemic infection with high mortality rates in koi fish (Cyprinus carpio).
Eva Marie Quijano Cardé   +6 more
doaj   +1 more source

The Role of Pharmacists in Tackling Mpox: Challenges and Future Prospects: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Pharmacists play a key role in managing and mitigating mpox through clinical care, pharmacovigilance, vaccine management, and resilient supply chains. Management focuses on supportive care, infection prevention, and accurate diagnosis, with pharmacists ensuring the availability and rational use of vaccines, disinfectants ...
Ayalew Sirbemo Degebo   +4 more
wiley   +1 more source

Airway Papillomatosis: New Treatments for an Old Challenge

open access: yesFrontiers in Pediatrics, 2019
Recurrent respiratory papillomatosis (RRP) is the recurrent growth of small, benign tumors, or papillomas, in the respiratory tract, caused by human papillomavirus (HPV). Currently, there is no cure.
Nankee Kumar   +2 more
doaj   +1 more source

Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks

open access: yesHealth Science Reports, 2022
Background and aims There is a sought for vaccines and antiviral agents as countermeasures for the recent monkeypox outbreak. Here, we aimed to review and discuss the repurposing potentials of smallpox vaccines and drugs in monkeypox outbreaks based on ...
Md. Rabiul Islam   +6 more
doaj   +1 more source

The Patient Perspective of Living With Recurrent Respiratory Papillomatosis

open access: yesThe Laryngoscope, Volume 136, Issue 7, Page 3067-3078, July 2026.
This study was conducted to better understand the perspectives and real‐world impact of the disease burden on patients diagnosed with recurrent respiratory papillomatosis (RRP) and caregivers who experience the disease daily. RRP results in clinical, financial, and psychosocial burdens. Increased public awareness of human papillomavirus (HPV) infection
Sara I. Pai   +7 more
wiley   +1 more source

Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery

open access: yesChemical Biology &Drug Design, Volume 108, Issue 1, July 2026.
A stepwise translational framework linking natural‐product discovery, computational prioritisation, experimental validation, lead optimisation and targeted delivery is proposed to advance antiviral design. ABSTRACT The COVID‐19 pandemic highlighted the role of rapid viral mutation and global connectivity in accelerating viral emergence and spread ...
Adedayo Ayodeji Lanrewaju   +3 more
wiley   +1 more source

Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects

open access: yesBiomedicines, 2023
The monkeypox disease (MPX) outbreak of 2022 has been reported in more than one hundred countries and is becoming a global concern. Unfortunately, only a few treatments, such as tecovirimat (TCV), are available against MPX.
Mohd. Imran   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy